Sr. Manager, Lung Portfolio Marketing
Pfizer· 4 Locations
manager $124k – $207k / year seen live 2 days ago
ROLE SUMMARY The Lung cancer portfolio is one of the fastest growing portfolios in Pfizer Oncology and includes the following brands: LORBRENA, BRAFTOVI/MEKTOVI Lung and XALKORI. Lung cancer is the most common cancer, and LORBRENA, our ALK+ inhibitor has been prescribed to
This link goes straight to the employer's workday page. Posted 3 days ago.We last confirmed it was open 2 days ago.